In separate studies using patient-derived samples of colon cancer or rectal cancer, it was found that CD133-positive cells are mainly located in the hypoxic fractions of tumors, but the expression level of CD133 is inversely correlated with that of HIF-1α in patients receiving preoperative chemoradiotherapy. Here, PROM1 is linked to rectal cancer.